1. Home
  2. LIQT vs SKYE Comparison

LIQT vs SKYE Comparison

Compare LIQT & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$0.65

Market Cap

28.8M

Sector

Technology

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.65

Market Cap

24.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIQT
SKYE
Founded
2004
2012
Country
Denmark
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.8M
24.7M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
LIQT
SKYE
Price
$0.65
$0.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.30
$15.00
AVG Volume (30 Days)
191.7K
108.6K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.12
N/A
Revenue Next Year
$63.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.57
52 Week High
$3.35
$4.99

Technical Indicators

Market Signals
Indicator
LIQT
SKYE
Relative Strength Index (RSI) 30.59 46.19
Support Level N/A $0.57
Resistance Level $2.08 $0.84
Average True Range (ATR) 0.08 0.04
MACD 0.01 0.00
Stochastic Oscillator 5.86 63.09

Price Performance

Historical Comparison
LIQT
SKYE

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: